Why is GKB Ophthalmics falling/rising?

As of 07-Oct, GKB Ophthalmics Ltd is currently priced at 66.70, reflecting a slight increase of 0.12 or 0.18%. Despite this uptick, the stock has shown a negative performance over various time frames, including a decline of 7.89% over the past month and 32.46% year-to-date. Today's price summary indicates that GKB Ophthalmics has outperformed its sector by 0.92%, although it is trading below its moving averages across multiple periods, suggesting a bearish trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 81.66% compared to the 5-day average, which may indicate growing interest despite the overall downward trajectory.
In the broader market context, the stock's performance has lagged behind the Sensex, which has gained 2.07% over the past week. This underperformance is evident in the longer-term comparisons as well, with GKB Ophthalmics experiencing a 46.19% decline over the past three years, while the Sensex has risen by 40.79%. The liquidity of the stock remains adequate, allowing for trades of significant size, but the overall negative returns compared to the benchmark highlight the challenges the company faces in regaining investor confidence.